These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 503208)

  • 1. Epidermal Langerhans cells are derived from cells originating in bone marrow.
    Katz SI; Tamaki K; Sachs DH
    Nature; 1979 Nov; 282(5736):324-6. PubMed ID: 503208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origin of Langerhans cells.
    Tamaki K; Stingl G; Katz SI
    J Invest Dermatol; 1980 May; 74(5):309-11. PubMed ID: 7391603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow origin of Ia molecules purified from epidermal cells.
    Frelinger JA; Frelinger JG
    J Invest Dermatol; 1980 Jul; 75(1):68-70. PubMed ID: 6967098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse epidermal Ia molecules have a bone marrow origin.
    Frelinger JG; Hood L; Hill S; Frelinger JA
    Nature; 1979 Nov; 282(5736):321-3. PubMed ID: 503207
    [No Abstract]   [Full Text] [Related]  

  • 5. Thy-1 antigen-bearing dendritic cells in murine epidermis are derived from bone marrow precursors.
    Bergstresser PR; Tigelaar RE; Streilein JW
    J Invest Dermatol; 1984 Aug; 83(2):83-7. PubMed ID: 6147381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated cytotoxicity to nonmajor histocompatibility complex alloantigens on mouse epidermal cells. V. Contribution of bone marrow-derived cells to Epa-1 antigen expression.
    Burlingham WJ; Steinmuller D
    Transplantation; 1983 Feb; 35(2):130-5. PubMed ID: 6600858
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells.
    Sullivan S; Bergstresser PR; Tigelaar RE; Streilein JW
    J Immunol; 1986 Oct; 137(8):2460-7. PubMed ID: 2876041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period.
    Elbe A; Tschachler E; Steiner G; Binder A; Wolff K; Stingl G
    J Immunol; 1989 Oct; 143(8):2431-8. PubMed ID: 2571637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.
    Teunissen MB
    Histochem J; 1992 Oct; 24(10):697-716. PubMed ID: 1428996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Langerhans cell.
    Wolff K; Stingl G
    J Invest Dermatol; 1983 Jun; 80 Suppl():17s-21s. PubMed ID: 6343515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional role of Langerhans cells.
    Stingl G; Katz SI; Green I; Shevach EM
    J Invest Dermatol; 1980 May; 74(5):315-8. PubMed ID: 6967097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of epidermal Langerhans cells by immunoadsorption to Staphylococcus aureus cells.
    Schuler G; Auböck J; Linert J
    J Immunol; 1983 May; 130(5):2008-10. PubMed ID: 6339619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration and maturation of Langerhans cells in skin transplants and explants.
    Larsen CP; Steinman RM; Witmer-Pack M; Hankins DF; Morris PJ; Austyn JM
    J Exp Med; 1990 Nov; 172(5):1483-93. PubMed ID: 2230654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine epidermal Langerhans cells express significant amounts of class I major histocompatibility complex antigens.
    Lenz A; Heufler C; Rammensee HG; Glassl H; Koch F; Romani N; Schuler G
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7527-31. PubMed ID: 2798423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.
    Heufler C; Koch F; Schuler G
    J Exp Med; 1988 Feb; 167(2):700-5. PubMed ID: 3279156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.